Groowe Groowe / Newsroom / ZURA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ZURA News

Zura Bio Limited Class A Ordinary Shares

Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

businesswire.com
ZURA

Form 8-K/A

sec.gov
ZURA

Form 8-K

sec.gov
ZURA

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

businesswire.com
ZURA

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

businesswire.com
ZURA

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

businesswire.com
ZURA

Form 8-K

sec.gov
ZURA

Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit

businesswire.com
ZURA

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer

businesswire.com
ZURA

Zura Bio Reports Business Updates and Outlook for 2026

businesswire.com
ZURA